戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ual patients (555 in men and 378 in women on continuous ambulatory peritoneal dialysis).
2 ed by patients with renal failure treated by continuous ambulatory peritoneal dialysis.
3 ravenously every 24 h in patients undergoing continuous ambulatory peritoneal dialysis.
4 and the peritoneum of individuals undergoing continuous ambulatory peritoneal dialysis.
5 3 were receiving hemodialysis and 41 were on continuous ambulatory peritoneal dialysis.
6 lar hypertension, dialysis (hemodialysis and continuous ambulatory peritoneal dialysis), and transpla
7 r group was studied before the initiation of continuous ambulatory peritoneal dialysis (CAPD) and 2 w
8  some patients with peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD), a caus
9                We describe the first case of continuous ambulatory peritoneal dialysis (CAPD)-related
10 cultures on all specimens except for tissue, continuous ambulatory peritoneal dialysis fluid, and CSF
11  that occurs frequently in humans undergoing continuous ambulatory peritoneal dialysis for end-stage
12  (weight, height, V, BSA) in 301 patients on continuous ambulatory peritoneal dialysis (four daily ex
13 d peritoneal clearances in large subjects on continuous ambulatory peritoneal dialysis is a low norma
14  tarda in an adult ESRD patient treated with continuous ambulatory peritoneal dialysis is described.
15 y Roseomonas gilardii in a patient receiving continuous ambulatory peritoneal dialysis is presented.
16                                              Continuous ambulatory peritoneal dialysis patients are a
17 In the clearance studies performed in actual continuous ambulatory peritoneal dialysis patients, the

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。